Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Ligand Pharmaceuticals history
Ligand Pharmaceuticals company history timeline
In December 1989, it also changed its name to Ligand, an allusion to the scientific term for the chemical complex that forms around a central atom or molecule.
Ligand in 1991, with no sales and only 71 employees, was still very much a small company, especially compared to Erbamont and its $1 billion in annual revenues and 9,000 employees.
In June 1992, Ligand and Allergan Inc. agreed to work together on skin disorders, in particular Kaposi's sarcoma, caused by AIDS. Under terms of the deal, Allergan paid $20 million to gain a stake in Ligand.
In the spring of 1992, Robinson was also preparing to make an initial public offering (IPO) of Ligand's stock, but when biotech stocks fell off, the IPO had to be postponed.
Acquisition of Glycomed: 1995
Early in May 1998, SmithKline Beecham agreed to a collaboration deal to develop oral drugs to prevent obesity.
He improved his chances to meet that goal when in October 1998 he forged an alliance with Elan Corporation, an Ireland-based pharmaceutical.
1998: Seragen Inc. is acquired.
1999: Ligand has two drugs approved by the FDA in the same week.
Rate how well Ligand Pharmaceuticals lives up to its initial vision.
Ligand Pharmaceuticals jobs
Do you work at Ligand Pharmaceuticals?
Is Ligand Pharmaceuticals' vision a big part of strategic planning?
Ligand Pharmaceuticals competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | 1891 | $64.2B | 74,000 | 1,930 |
| Nektar Therapeutics | 1990 | $98.4M | 718 | - |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 614 |
| Alnylam Pharmaceuticals | 2002 | $2.2B | 1,323 | 1 |
| Regeneron | 1988 | $14.2B | 9,123 | 398 |
| Forest Laboratories | 1954 | $3.6B | 6,200 | - |
| Human Genome Sciences | 1992 | $131.0M | 1,000 | - |
| Pharmaceutical | 1929 | $2.7B | 5,700 | 118 |
| Cubist Pharmaceuticals | 1992 | $926.4M | 873 | - |
| Hoffmann-LA Roche Inc | 1896 | $60.9B | 101,200 | 112 |
Ligand Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of Ligand Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ligand Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Ligand Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ligand Pharmaceuticals. The data presented on this page does not represent the view of Ligand Pharmaceuticals and its employees or that of Zippia.
Ligand Pharmaceuticals may also be known as or be related to LIGAND PHARMACEUTICALS INC, Ligand Pharmaceuticals, Ligand Pharmaceuticals Incorporated, Ligand Pharmaceuticals, Inc. and Ligand Pharmaceuticals,Inc.